Get 20% lifetime commission for referring investors to digrin.com
here.
Matinas BioPharma Holdings, Inc. ( MTNB) - Stock Earnings
MTNB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
MTNB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.9 million USD | — USD |
| 2026Q1 | -1.9 million USD | — USD |
| 2026Q2 | -1.3 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MTNB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.9 million USD | 1.1 million USD |
| 2024 | -24.3 million USD | — USD |
| 2025 | -10.3 million USD | — USD |
| 2026 Est. | — | — |
MTNB
Price: $2.37
52 week price:
Earnings Per Share: -1.15 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 237100
Market Capitalization: 1.2 million